Is the dog a useful model for accelerated calcification study of cardiovascular bioprosthesis?

Artificial Organs

Volumn 21, Issue 5, 1997, Pages 391-395

  Chanda, Jyotirmay ^a   Kuribayashi, Ryosei ^a   Abe, Tadaaki ^a   Sekine, Satoshi ^a   Shibata, Yoshiki ^a   Yamagishi, Itsuro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

aortic surgery; apicoaortic shunt; bioprosthetic valved conduit; chitosan; glutaraldehyde

Indexed keywords

BIOMINERALIZATION; BONE; CALCIUM; CHITOSAN;

AORTIC SURGERY; AORTIC VALVES; APICOAORTIC SHUNT; BIOPROSTHESES; BIOPROSTHETIC VALVED CONDUIT; BOVINE PERICARDIUM; CHITOSAN; GLUTARALDEHYDES; POST TREATMENT; SYSTEMIC CIRCULATION;

BLOOD VESSELS;

CHITOSAN; GLUTARALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SURGERY; AORTA VALVE PROSTHESIS; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CONTROLLED STUDY; DRUG EFFICACY; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; BOVINAE; CANIS FAMILIARIS; SUIDAE;

EID: 0031000536     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00735.x     Document Type: Article

References (22)

1. Horstkotte D, Korfer R, Seipel L, Looge NF. Late complications in patients with Björk-Shiley and St. Jude medical heart valve replacement. Circulation 1983;68:(Suppl 2):175-85.
2. Angell WW, Oury JH, Shah P. A comparison of replacement and reconstruction in patients with mitral regurgitation. J Thorac Cardiovasc Surg 1987;93:665-74.
3. Duran C, Kumar N, Gometza B, Alhalees A. Indications and limitations of aortic valve reconstruction. Ann Thorac Surg 1991;52:447-54.
4. Duran CG, Revuelta JM, Gaite L. Stability of mitral reconstructive surgery at 10-12 years for predominantly rheumatic valvular disease. Circulation 1988;(Suppl 1):91-6.
5. Salazar E, Zajaris A, Gutierezz N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants, and pregnancy. Circulation 1984;70(Suppl 1):169-70.
6. Jamieson WRE, Miller DC, Akins CW, Munro AI, Glower DD, Moore KA, Henderson C. Pregnancy and bioprostheses: Influence on the structural valve deterioration. Ann Thorac Surg 1996;60:S282-7.
7. Gallo I, Ruiz B, Nistal F, Duran CMG. Degeneration in porcine bioprosthetic cardiac valves: Incidence of primary tissue failure among 938 bioprostheses at risk. Am J Cardiol 1984; 53:1061-5.
8. Pomar JL, Bosch X, Chaitman BR, Pelletier C, Grondin CM. Late tears in leaflets of porcine bioprostheses in adults. Ann Thorac Surg 1983;36:246-52.
9. Gallo I, Nistal F, Artinano E. Six- to ten-year follow-up of patients with the Hancock cardiac bioprostheses. J Thorac Cardiovasc Surg 1986;92:14-20.
10. Jamieson WRE, Munro I, Miyagishima RT, Burr LH, Gerein AN, Janusz MT, Tyres GFO, Allen P. The Carpentier-Edwards supraannular porcine bioprosthesis. A new generation tissue valve with excellent intermediate clinical performance. J Thorac Cardiovasc Surg 1988;96:652-66.
11. Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials 1994;15:465-9.
12. Chanda J, Rao SB, Mohanty M, Lal AV, Muraleedharan CV, Bhuvaneshwar GS, Valiathan MS. Prevention of calcification of tissue valves. Artif Organs 1994;18:752-7.
13. Chanda J. Prevention of calcification of heart valve bioprostheses: An experimental study in rat. Ann Thorac Surg 1995; 60:S339-42.
14. Chanda J. Posttreatment with amino compounds effective in prevention of calcification of glutaraldehyde treated pericardium. Artif Organs 1994;18:408-10.
15. Kuribayashi R, Chanda J, Abe T. Efficacy of the chitosan posttreatment in calcification prevention of the glutaraldehyde treated porcine aortic noncoronary cusp implanted in the right ventricular outflow tract in dogs. Artif Organs 1996;20:761-6.
16. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via modified reducing terminal residue. Biomater Med Devices Artif Organs 1983;11:161-73.
17. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol 1986;123:134-45.
18. Lynn LH, Lee H, Cheung DT, Nimni ME. Biochemical changes and cytotoxicity associated with the dehydration of polymeric glutaraldehyde derived crosslinks. J Biomed Mater Res 1990;24:1185-91.
19. Schoen FJ, Levy RJ, Hilbert SL, Bianco RW. Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety. J Thorac Cardiovasc Surg 1992;104: 1285-8.
20. Okamura K, Chiba C, Iriyama T, Itoh T, Maeta H, Ijima H, Mitsui T, Hori M. Antigen depressant effect of glutaraldehyde for heterografts with a valve, with special reference to a concentration right fit for the preservation of grafts. Surgery 1980;87:170-6.
21. Shemin RJ, Schoen FJ, Hein R, Austin J, Cohn LH. Hemodynamic and pathologic evaluation of a unileaflet pericardial bioprosthetic valve. J Thorac Cardiovasc Surg 1988;95:912-9.
22. Ketharnathan V, Christie BA. Glutaraldehyde-tanned ovine collagen conduits as vascular xenografts in dogs. Arch Surg 1980;115:967-9.